A team of researchers from five Swedish universities have made a remarkable breakthrough in the treatment of cancer, with an equally innovative source of funding.
Led by Karolinska Institutet and the Science for Life Laboratory in Stockholm, the team has made inhibitors that kill cancer cells but not normal cells.
“We are first to show this new way of targeting cancer and this is likely going to be the major path for drug development in the future,” said Thomas Helleday, holder of the Söderberg Professorship at Karolinska Institutet, who heads the study.
Until now, most modern anti-cancer drugs have been tailored to target the genetic makeup of the cancer – a so-called personalized treatment. Sometimes this can have a long-lasting effect, but more often than not the cancers mutate to become resistant. What the team has managed to do is to target an enzyme that is required for all cancer cells for survival, but that normal cells do not need.
Helleday explained that the treatment – which comes in the form of a pill – can kill any cancer and does not have any severe side effects.
“Some say our finding sounds too good to be true, and I understand their gut feeling after seeing so many promising cancer treatments fail,” he said. “My research group has made paradigm shifts before and to those skeptics I say: just sit back and enjoy the revolution!”
What’s also revolutionary is the way the research is financed, through “open innovation” and “crowd sourcing”.
“I started a public foundation that owns all intellectual property and the idea is that we manufacture large amounts of the drug and provide it for free to the worldwide academic community, so they can design their own clinical trials and run them”, Helleday said.
“Also, as there is a public foundation behind the drug, it will not be used to enrich a few individuals, but be used for further work on new medicines.”
A lot of work remains to be done before it is time for clinical trials, which are still a year or two away, Helleday said.
Being based in Stockholm brings many advantages, including a number of highly trained drug developers looking for new challenges, he said.
“A major point is that Swedish Universities do not claim or take control on intellectual property, allowing us to donate it to a public foundation,” Helleday said.
“Another advantage is the collaborative nature of Swedes. We collaborated with five different universities to progress the project, which would have been difficult elsewhere.”
Their concept is presented in two articles in science journal Nature, with the aim of spreading the word to as many as possible in the research community.
“It has generated interest from academics across the world, to try the new concept on the cancer indication they have specialized in,” Helleday said.
The team has also sent out the compound to hundreds of scientists across the globe in an effort to increase the speed of innovation and to reach the goal of curing cancer more quickly. By freely sending out compounds, they have increased competition.
“Hundreds of scientists are advancing more quickly than one and we increase the chances of overall success,” Helleday said.
The Latest on: Cancer breakthrough
[google_news title=”” keyword=”Cancer breakthrough” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Cancer breakthrough
- New blood test for 50 types of cancer sparks hope of ‘revolutionary’ breakthroughon June 2, 2023 at 11:32 pm
A blood test that can detect more than 50 different types of cancer could speed up diagnosis, a new study suggests. The Galleri test was able to detect signs of cancer in 323 out of the 6,238 people ...
- Australian researchers achieve breakthrough in endometriosis researchon June 2, 2023 at 1:45 pm
Researchers at the Royal Hospital for Women in Sydney, Australia, have made a groundbreaking discovery that could help in the treatment of women suffering from endometriosis. The Sydney researchers ...
- Breast Cancer Drug Could Reduce Chances of Disease Coming Backon June 2, 2023 at 12:48 pm
The fight against breast cancer is nearing a possible breakthrough. Kisqali is a breast cancer drug that has been on the market for some time now. It has now been found to lower the reoccurrence rate ...
- Blood test for 50 types of cancer could speed up diagnosis in huge breakthrough, study suggestson June 2, 2023 at 12:39 pm
A blood test for cancer could help speed up diagnosis and reduce a backlog of patients for treatment, new data suggests. An NHS trial found the Galleri blood test correctly revealed two out of every ...
- Researchers claim 'major breakthrough' in endometriosis treatmenton June 2, 2023 at 6:22 am
Researchers say they have made a breakthrough in diagnosing and treating endometriosis, a condition that affects 10% of women ages 15-44.
- Major cancer breakthrough as world-first blood test can detect 50 types of diseaseon June 2, 2023 at 5:01 am
A simple blood test aims to detect more than 50 types of cancer which is a valuable tool that could help diagnose more patients.
- How mutations to a key liver cancer pathway contribute to tumor progressionon June 1, 2023 at 8:04 am
New Peter Mac research recently published in Proceedings of the National Academy of Sciences (PNAS) has discovered a fundamental breakthrough related to the development of liver cancer.
- Israeli cancer breakthrough says which patients should get immunotherapyon May 31, 2023 at 10:51 am
Since anti-PD1 is the leading immunotherapy treatment in cancer patients, such an achievement can impact the quality of life of thousands of cancer patients worldwide every day.
- Breakthrough cancer treatment is not something insurance will cover: Dr. Marc Siegelon May 31, 2023 at 6:43 am
Fox News medical contributor Dr. Marc Siegel joined ‘Mornings with Maria’ to discuss the Israeli cancer treatment that is reporting a 90% success rate.
- Cancer breakthrough as new drug could destroy the deadliest brain tumourson May 26, 2023 at 7:08 am
What’s more, the breakthrough has potential implications ... our substance on other aggressive tumour forms like pancreatic cancer, triple-negative breast cancer and certain liver cancers." ...
via Bing News